Emma L. Matthews

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Treatment updates in myotonic disorders.

Treatment updates in myotonic disorders.

Journal: Journal of neurology

Published: July 13, 2026

Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1.

Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1.

Journal: Neurology

Published: February 26, 2026

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Journal: Muscle & nerve

Published: December 05, 2025

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

Journal: PloS one

Published: September 11, 2025

CD3+TCRαβ/CD19+-depleted stem cell boost and CD45RO+ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT.

CD3+TCRαβ/CD19+-depleted stem cell boost and CD45RO+ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT.

Journal: Pediatric blood & cancer

Published: May 19, 2024

Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial.

Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial.

Journal: The Lancet. Neurology

Published: May 07, 2024

Crossover randomized controlled trial of bumetanide to rescue an attack of exercise induced hand weakness in hypokalaemic periodic paralysis.

Crossover randomized controlled trial of bumetanide to rescue an attack of exercise induced hand weakness in hypokalaemic periodic paralysis.

Journal: Neuromuscular disorders : NMD

Published: September 19, 2023

Leigh syndrome with developmental regression and ataxia due to a novel splicing variant in the PMPCB gene.

Leigh syndrome with developmental regression and ataxia due to a novel splicing variant in the PMPCB gene.

Journal: Journal of human genetics

Published: September 18, 2023

Care Recommendations for the Investigation and Management of Children With Skeletal Muscle Channelopathies.

Care Recommendations for the Investigation and Management of Children With Skeletal Muscle Channelopathies.

Journal: Pediatric neurology

Published: March 06, 2023

Integrin α7 Mutations Are Associated With Adult-Onset Cardiac Dysfunction in Humans and Mice.

Integrin α7 Mutations Are Associated With Adult-Onset Cardiac Dysfunction in Humans and Mice.

Journal: Journal of the American Heart Association

Published: November 29, 2022

Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation.

Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation.

Journal: Muscle & nerve

Published: November 03, 2022

Investigating genotype-phenotype relationship of extreme neuropathic pain disorders in a UK national cohort.

Investigating genotype-phenotype relationship of extreme neuropathic pain disorders in a UK national cohort.

Journal: Brain communications

Published: August 15, 2022

Showing 1-12 of 81

Last Updated: 09/26/2026